This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Conferences
Recent Abstracts
AUA 2016: Reporting Standards of Indeterminate Renal Masses on CT and MRI: A National Survey of Urologists and Radiologists by the Society of Abdominal Radiology RCC Disease-Focused Panel - Session Highlights
May 7, 2016
AUA 2016: Automated Stone Volume Measurement Using Reduced-Dose (RD) CT Is Comparable Standard-Dose (SD) CT - Session Highlights
May 7, 2016
AUA 2016: Moderate chronic kidney disease (eGFR n bladder cancer patients treated with transurethral resection - Session Highlights
May 7, 2016
AUA 2016: The Significance of Anterior Prostate Lesions on Multiparametric MRI In African American Men - Session Highlights
May 7, 2016
AUA 2016: Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study - Session Highlights
May 7, 2016
AUA 2016: Validation of 3-D Volumetric Based Renal Function Prediction Calculator for Nephron Sparing Surgery - Session Highlights
May 7, 2016
AUA 2016: Comorbidity status as a predictor of high-grade status as a predictor of high-grade disease in men with prostate cancer - Session Highlights
May 7, 2016
AUA 2016: Pathophysiological relationship between pelvic organ prolapse and overactive bladder - Session Highlights
May 7, 2016
AUA 2016: Predictors of Genitourinary Malignancy Among Patients with Primary Microscopic Hematuria - Session Highlights
May 7, 2016
AUA 2016: Assessing the relative contribution of hospital and surgeon volume on short term mortality outcomes following radical cystectomy - Session Highlights
May 7, 2016
AUA 2016: Long-term outcomes of abdominal vs. vaginal apical prolapse repair among female Medicare beneficiaries - Session Highlights
May 7, 2016
AUA 2016: New Strategies for Infection Control: Insights from Evolutionary Ecology - Session Highlights
May 6, 2016
Tele-Urology Improves Access and Quality of Care for Patients
May 6, 2016
AUA 2016: Improving radical cystectomy care: outcomes, compliance, and barriers to adoption for a new protocol - Session Highlights
May 6, 2016
AUA 2016: Trends in Regionalization of Care and Mortality for Patients Treated with Radical Cystectomy - Session Highlights
May 6, 2016
AUA 2016: Identifying mRCC Patients with Venous Thrombus Who Are Likely to Benefit from Cytoreductive Surgery - Session Highlights
May 6, 2016
AUA 2016: Brantley Scott Lecture: Overview of Medical Device Concepts of Artificial Urinary Sphincters - Session Highlights
May 6, 2016
Projected Climate Change and Rise in Obesity Levels Expected to Increase Burden of Stone Disease
May 6, 2016
AUA 2016: Anti-PDL and anti-PDL-1 trials in bladder cancer - Session Highlights
May 6, 2016
AUA 2016: Association of Distance to Treatment Facility with Survival and Quality Outcomes Following Radical Cystectomy: A Multi-Institutional Study - Poster Session Highlights
May 6, 2016
Page 508 of 594
Start
Prev
503
504
505
506
507
508
509
510
511
512
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free